ZA882347B - Amino acid derivatives - Google Patents

Amino acid derivatives

Info

Publication number
ZA882347B
ZA882347B ZA882347A ZA882347A ZA882347B ZA 882347 B ZA882347 B ZA 882347B ZA 882347 A ZA882347 A ZA 882347A ZA 882347 A ZA882347 A ZA 882347A ZA 882347 B ZA882347 B ZA 882347B
Authority
ZA
South Africa
Prior art keywords
amino acid
acid derivatives
derivatives
amino
acid
Prior art date
Application number
ZA882347A
Inventor
Weber Wolf-Dietrich
Hoelzemann Guenter
Jonczyk Alfred
Wild Albrecht
Lues Ingeborg
Wienrich Marion
Greiner Hartmut
Original Assignee
Merck Patent Gesellschaft Mit Beschraenkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschraenkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschraenkter Haftung
Publication of ZA882347B publication Critical patent/ZA882347B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA882347A 1987-04-03 1988-03-31 Amino acid derivatives ZA882347B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873711335 DE3711335A1 (en) 1987-04-03 1987-04-03 AMINO ACID DERIVATIVES

Publications (1)

Publication Number Publication Date
ZA882347B true ZA882347B (en) 1988-09-23

Family

ID=6324839

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882347A ZA882347B (en) 1987-04-03 1988-03-31 Amino acid derivatives

Country Status (7)

Country Link
EP (1) EP0284942A3 (en)
JP (1) JPS63258894A (en)
KR (1) KR880012641A (en)
AU (1) AU1413488A (en)
DE (1) DE3711335A1 (en)
HU (1) HUT49149A (en)
ZA (1) ZA882347B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
AU638264B2 (en) * 1989-08-10 1993-06-24 Aventis Inc. Cyclic neurokinin a antagonists
WO1991012266A1 (en) * 1990-02-15 1991-08-22 Fujisawa Pharmaceutical Co., Ltd. Peptide compound
DE4007869A1 (en) * 1990-03-13 1991-09-19 Merck Patent Gmbh AMINOSAEUREDERIVATE
AU646966B2 (en) * 1991-08-23 1994-03-10 Takeda Chemical Industries Ltd. 2-piperazinone compounds, their production and use
EP0916346A3 (en) 1991-09-20 2000-12-06 Glaxo Group Limited NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
GR1001405B (en) * 1992-05-15 1993-11-30 Takeda Chemical Industries Ltd 2-piperazinone compounds, the preparation and use thereof.
DE4302485A1 (en) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazine derivatives
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
PL330348A1 (en) 1996-06-07 1999-05-10 Zeneca Ltd Peptidic derivatives
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
AU7127298A (en) * 1997-04-14 1998-11-11 Emory University Serine protease inhibitors
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
UA105182C2 (en) 2008-07-03 2014-04-25 Ньюрексон, Інк. Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378121D1 (en) * 1982-10-18 1988-11-03 Ici Plc PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES
EP0176436A3 (en) * 1984-09-26 1987-12-16 Merck & Co. Inc. Analogs of substance p and eledoisin

Also Published As

Publication number Publication date
DE3711335A1 (en) 1988-10-20
HUT49149A (en) 1989-08-28
AU1413488A (en) 1988-10-06
JPS63258894A (en) 1988-10-26
EP0284942A3 (en) 1990-09-05
EP0284942A2 (en) 1988-10-05
KR880012641A (en) 1988-11-28

Similar Documents

Publication Publication Date Title
ZA877950B (en) Amino acid derivatives
ZA902185B (en) Amino acid derivatives
EP0416373A3 (en) Amino acid derivatives
AU1261788A (en) Amino acid derivatives
ZA882347B (en) Amino acid derivatives
ZA887322B (en) Amino acid derivatives
EP0231996A3 (en) Novel amino acid derivatives
ZA875692B (en) Amino acid derivatives
ZA893199B (en) Amino acid derivatives
ZA887373B (en) Amino acid derivatives
ZA892720B (en) Amino acid derivatives
ZA883782B (en) Amino acid derivatives
ZA899114B (en) Amino acid derivatives
ZA892059B (en) Amino acid derivatives
ZA902395B (en) Amino acid derivatives
GB8707515D0 (en) Amino acid derivatives
ZA891265B (en) Amino acid derivatives
ZA881782B (en) Amino acid derivatives
IE870513L (en) Amino acid derivatives
IE872833L (en) Amino acid derivatives
IE872080L (en) Amino acid derivatives
IE871528L (en) Amino acid derivatives
IE870512L (en) Amino acid derivatives
IE860546L (en) Amino acid derivatives
IE863019L (en) Amino acid derivatives